Serum samples (1,428) from 1,149 patients with chronic liver diseases and polfiransfused subjects were tested for antibody to hepatitis C virus by first-generation enzyme immunoassays. Antibody to hepatitis C virus was detected in 87% of patients with transfusion-related chronic non-A, non-B hepatit
Longterm status of antibody to hepatitis C virus and the relation to the outcome of hepatitis: A retrospective study using stored sera from patients with Sashima epidemic hepatitis
β Scribed by Aramaki, Takumi ;Wakayama, Yoko ;Akaike, Masahiro ;Satomura, Katsuaki ;Katsuta, Yasumi ;Okumura, Hidemasa
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 240 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a retrospective study, antibody to hepatitis C virus (anti-HCV antibody) was measured in 80 patients with acute viral hepatitis (type A, 18; type B, 21; type non-A,non-B, 41). Anti-HCV antibody was found in 12 of 20 patients (60%) with non-A,non-B post-transfusion hepatitis (NANB-PTH) and in 9 of
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for
## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzymeβlinked immunosorbent assay based on genotypeβspecific recombinant peptides of the NS4